2019-07-17 // 0 Comments
CITY, Country, 2019-Jul-17 — /EPR Network/ — Dasatinib (Sprycel) medicines are generally used to treat people with chronic myeloid leukemia and people with acute lymphoblastic [read full press release…]
Home | Submit Press Release | Nationwide / EPR Network | Free Press Release Distribution | Real Time Press Release Distribution | Travel PR News | EuropaWire
© 2004-2024 Express-Press-Release.Net. Owned by EPR Network LLC. All Rights Reserved. All trade marks and names are owned by their respective owners.
RSS | Privacy | Disclaimer | TOS | Feedback
EPR Network LLC disclaims any content found in press releases published on its network - full disclaimer. Powered by WP. Theme by MH Themes
In the works: Consolidated Press Release Distribution | Social Press Release | Early Bird Press Release
|
The entire EPR Network is up for sale!
|